Neutral
BlackRock (SPRY) files amendment showing 4.98% ownership
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing beneficial ownership of 4,946,412 shares of ARS Pharmaceuticals, Inc. common st...
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing beneficial ownership of 4,946,412 shares of ARS Pharmaceuticals, Inc. common st...